share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/26 18:15
Moomoo AI 已提取核心信息
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
据报道，诺瓦瓦克斯公司（NVAX）总裁兼首席执行官约翰·雅各布斯于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告没有提供有关雅各布斯在行动后持有的股票数量的信息。
据报道，诺瓦瓦克斯公司（NVAX）总裁兼首席执行官约翰·雅各布斯于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告没有提供有关雅各布斯在行动后持有的股票数量的信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息